Corbus Pharmaceuticals Holding (CRBP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $69.86M
Last updated: Nov 17, 2026 at 4:37 PM ET
Corbus Pharmaceuticals Holding (CRBP) Stock Chart
Corbus Pharmaceuticals Holding (CRBP) has a latest price of $3.01 on Nov 17, 2026, 76.6% below its 52-week high of $12.88. Its price fell 72.8% over the past 12 months. The month-end price fell 97.5% over the 10 years through Oct 2026, a compound annual decline of 30.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $278.83 in Aug 2020 and its lowest $2.99 in Feb 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CRBP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRBP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 69.9%, and over 6 months it fell 67.1%. The month-end price fell 22.6% over the 3 years through Oct 2026, a compound annual decline of 8.2%.
| Period | Change |
|---|---|
| 1 month | -32.5% |
| 3 months | -69.9% |
| 6 months | -67.1% |
| 12 months | -72.8% |
| 12 months, with dividends | -72.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -22.6% | -8.2% |
| 5 years | -85.9% | -32.5% |
| 10 years | -97.5% | -30.8% |
Price by Year
Its best calendar year was 2024, when the price rose 95.4%, and its weakest was 2022, when it fell 82.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.22 | -48.2% |
| 2025 | $8.14 | -31.0% |
| 2024 | $11.80 | +95.4% |
| 2023 | $6.04 | +82.0% |
| 2022 | $3.32 | -82.1% |
| 2021 | $18.49 | -50.7% |
| 2020 | $37.54 | -77.1% |
| 2019 | $163.96 | -6.5% |
| 2018 | $175.38 | -17.7% |
| 2017 | $213.21 | -16.0% |
Trading Range
The price is 43.9% below its 50-day average of $5.36 and 63.8% below its 200-day average of $8.31.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.01 | |
| 52-week high | $12.88 | -76.6% |
| 52-week low | $2.81 | +7.1% |
| 50-day average | $5.36 | -43.9% |
| 200-day average | $8.31 | -63.8% |
Price Risk
Over 3 years, its largest fall from a peak was 95.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.83 |
| Largest fall, 1 year | -76.5% |
| Largest fall, 3 years | -95.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CRBP
What is CRBP's 1-year price change?
Corbus Pharmaceuticals Holding's price fell 72.8% over the past 12 months. With dividends included, the 12-month total return was -72.8%.
What is CRBP's 5-year price change?
Corbus Pharmaceuticals Holding's month-end price fell 85.9% over the 5 years through Oct 2026, a compound annual decline of 32.5%. These figures leave out dividends.
What is CRBP's 52-week high and low?
Corbus Pharmaceuticals Holding's 52-week high is $12.88 and its 52-week low is $2.81. Its latest price of $3.01 on Nov 17, 2026 is 76.6% below the high.
What is CRBP's beta?
Corbus Pharmaceuticals Holding's 1-year beta against the S&P 500 is 1.83, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 76.5%.
Is the CRBP chart free?
Yes. Advanced Charting for CRBP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CRBP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors